Expert Opinion on Therapeutic Targets
| Discipline | Pharmacology, therapeutics |
|---|---|
| Language | English |
| Publication details | |
Former name(s) | Emerging Therapeutic Targets |
| History | 1997–present |
| Publisher | |
| Frequency | Monthly |
| 4.598 (2017) | |
| Standard abbreviations | |
| ISO 4 | Expert Opin. Ther. Targets |
| Indexing | |
| ISSN | 1472-8222 (print) 1744-7631 (web) |
| LCCN | 2002243135 |
| OCLC no. | 49275520 |
| Links | |
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001.
The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs
The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.
The journal is published by Informa. The Editor in Chief of the journal is Professor Daniele Santini, University Campus Bio-Medico, Rome, Italy
Indexing[edit]
Expert Opinion on Therapeutic Targets ranks #25 of 261 in the Pharmacology & Pharmacy category in the 2017 ISI Journal Citation Reports. The journal has a 2017 impact factor of 4.598.
The journal is indexed by Chemical Abstracts, Index Medicus/MEDLINE, ISI Alerting Services™, Science Citation Index Expanded, EMBASE/Excerpta Medica
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |